Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Healey ALS MyMatch Common Screening Protocol (MCSP) for Determining Preliminary Eligibility for ALS MyMatch Early Phase Clinical Trials

NCT07400393 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT07400393
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07400393 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Healey ALS MyMatch Common Screening Protocol (MCSP) for Determining Preliminary Eligibility for ALS MyMatch Early Phase Clinical Trials
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
August 31, 2026
Completion date
March 16, 2029
Enrollment
500 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

als, als (amyotrophic lateral sclerosis), als - amyotrophic lateral sclerosis